IL317254A - Method for producing recombinant aav particles - Google Patents
Method for producing recombinant aav particlesInfo
- Publication number
- IL317254A IL317254A IL317254A IL31725424A IL317254A IL 317254 A IL317254 A IL 317254A IL 317254 A IL317254 A IL 317254A IL 31725424 A IL31725424 A IL 31725424A IL 317254 A IL317254 A IL 317254A
- Authority
- IL
- Israel
- Prior art keywords
- recombinant aav
- producing recombinant
- aav particles
- particles
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22184964 | 2022-07-14 | ||
| PCT/EP2023/069338 WO2024013239A1 (en) | 2022-07-14 | 2023-07-12 | Method for producing recombinant aav particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL317254A true IL317254A (en) | 2025-01-01 |
Family
ID=82799885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL317254A IL317254A (en) | 2022-07-14 | 2023-07-12 | Method for producing recombinant aav particles |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250263746A1 (en) |
| EP (1) | EP4554604A1 (en) |
| JP (1) | JP2025524619A (en) |
| KR (1) | KR20250036743A (en) |
| CN (1) | CN119546320A (en) |
| AR (1) | AR129895A1 (en) |
| AU (1) | AU2023305838A1 (en) |
| CA (1) | CA3261054A1 (en) |
| IL (1) | IL317254A (en) |
| MX (1) | MX2025000378A (en) |
| TW (1) | TW202417619A (en) |
| WO (1) | WO2024013239A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120399044B (en) * | 2025-04-30 | 2026-04-03 | 尚纯生物科技(武汉)有限公司 | A nanobody that specifically binds to AAV2 and its application |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US6093699A (en) | 1987-07-09 | 2000-07-25 | The University Of Manitoba | Method for gene therapy involving suppression of an immune response |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| WO1994017810A1 (en) | 1993-02-12 | 1994-08-18 | The Wistar Institute Of Anatomy And Biology | Recombinant cytomegalovirus vaccine |
| WO1994023744A1 (en) | 1993-04-16 | 1994-10-27 | The Wistar Institute Of Anatomy And Biology | Recombinant cytomegalovirus vaccine |
| US5998205A (en) | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
| US6100242A (en) | 1995-02-28 | 2000-08-08 | The Regents Of The University Of California | Gene therapies for enhancing cardiac function |
| US6001650A (en) | 1995-08-03 | 1999-12-14 | Avigen, Inc. | High-efficiency wild-type-free AAV helper functions |
| US6004797A (en) | 1995-11-09 | 1999-12-21 | Avigen, Inc. | Adenovirus helper-free recombinant AAV Virion production |
| US6228646B1 (en) | 1996-03-07 | 2001-05-08 | The Regents Of The University Of California | Helper-free, totally defective adenovirus for gene therapy |
| DE19955558C2 (en) | 1999-11-18 | 2003-03-20 | Stefan Kochanek | Permanent amniocyte cell line, its production and use for the production of gene transfer vectors |
| US6593123B1 (en) | 2000-08-07 | 2003-07-15 | Avigen, Inc. | Large-scale recombinant adeno-associated virus (rAAV) production and purification |
| JP4559429B2 (en) | 2003-05-21 | 2010-10-06 | ジェンザイム・コーポレーション | Method for producing a recombinant AAV virion preparation substantially free of empty capsids |
| DE102005054628A1 (en) | 2005-11-16 | 2007-05-24 | Cevec Pharmaceuticals Gmbh | Process for the preparation of permanent human cell lines |
| EP2529020B1 (en) | 2010-01-28 | 2018-04-25 | The Children's Hospital of Philadelphia | A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
| EP3795581A3 (en) | 2011-08-24 | 2021-06-09 | The Board of Trustees of the Leland Stanford Junior University | New avv capsid proteins for nucleic acid transfer |
| JP6342886B2 (en) | 2012-04-18 | 2018-06-13 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia | Composition and method for highly efficient gene transfer using AAV capsid variants |
| NZ716102A (en) | 2013-07-22 | 2021-12-24 | The Children’S Hospital Of Philadelphia | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| EP3384015A4 (en) | 2015-12-01 | 2019-05-29 | Spark Therapeutics, Inc. | Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical use |
| WO2018226887A1 (en) | 2017-06-07 | 2018-12-13 | Spark Therapeutics, Inc. | ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION |
| EP3658250A4 (en) | 2017-06-30 | 2021-10-27 | Spark Therapeutics, Inc. | AAV VECTOR COLUMN PURIFICATION METHOD |
| EP4175969A4 (en) | 2020-07-01 | 2024-07-24 | Medimmune, LLC | CLEANING AGENTS AND METHOD FOR CLEANING A BIOTHERAPEUTIC PRODUCT |
-
2023
- 2023-07-12 WO PCT/EP2023/069338 patent/WO2024013239A1/en not_active Ceased
- 2023-07-12 JP JP2025501287A patent/JP2025524619A/en active Pending
- 2023-07-12 AR ARP230101817A patent/AR129895A1/en unknown
- 2023-07-12 AU AU2023305838A patent/AU2023305838A1/en active Pending
- 2023-07-12 IL IL317254A patent/IL317254A/en unknown
- 2023-07-12 CA CA3261054A patent/CA3261054A1/en active Pending
- 2023-07-12 EP EP23741393.5A patent/EP4554604A1/en active Pending
- 2023-07-12 CN CN202380053759.3A patent/CN119546320A/en active Pending
- 2023-07-12 KR KR1020247043418A patent/KR20250036743A/en active Pending
- 2023-07-13 TW TW112126190A patent/TW202417619A/en unknown
-
2025
- 2025-01-09 MX MX2025000378A patent/MX2025000378A/en unknown
- 2025-01-13 US US19/019,201 patent/US20250263746A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3261054A1 (en) | 2024-01-18 |
| WO2024013239A1 (en) | 2024-01-18 |
| KR20250036743A (en) | 2025-03-14 |
| CN119546320A (en) | 2025-02-28 |
| US20250263746A1 (en) | 2025-08-21 |
| MX2025000378A (en) | 2025-02-10 |
| AU2023305838A1 (en) | 2024-11-28 |
| AR129895A1 (en) | 2024-10-09 |
| JP2025524619A (en) | 2025-07-30 |
| EP4554604A1 (en) | 2025-05-21 |
| TW202417619A (en) | 2024-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202210745B (en) | Method for the production of aav | |
| IL284532A (en) | Methods and systems for producing aav particles | |
| IL304620A (en) | Method for purifying recombinant viral particles | |
| EP3918792A4 (en) | Method and apparatus for improved sub-block partitioning intra sub-partitions coding mode | |
| EP3909241A4 (en) | System and method for improving combined inter and intra prediction | |
| IL320190A (en) | Method of purifying full recombinant aav particles | |
| PL4134411T3 (en) | Method for modifying mineral raw material | |
| PH12021551680A1 (en) | Improved method for producing high purity lead | |
| EP4023661A4 (en) | Method for producing peptide compound | |
| EP3939959A4 (en) | Method for producing peptide compound | |
| EP3922638A4 (en) | Method for producing peptide compound | |
| IL287063A (en) | Method for producing biotissue-like structure | |
| GB202000903D0 (en) | Process for producing cardiomyocytes | |
| EP4169938A4 (en) | Method for purifying recombinant protein | |
| GB202019455D0 (en) | Method for producing virus | |
| SG11202107201YA (en) | Process for producing, isolating, and purifying modified recombinant proteins | |
| HK40104539A (en) | Method for purifying recombinant viral particles | |
| HUE072417T2 (en) | New systems for producing recombinant proteins | |
| IL319976A (en) | Method for producing glycoprotein compositions | |
| CA3285455A1 (en) | Method for the production of recombinant aav particle preparations | |
| IL320073A (en) | Method for increasing recombinant protein expression | |
| AU2022901541A0 (en) | Methods for producing polypeptide variants | |
| CA3278288A1 (en) | Method for glycoprotein modification | |
| HK40049499A (en) | Scalable method for recombinant aav production | |
| EP4257267A4 (en) | Method for producing aluminum-containing particles |